CompoAtlas

Kyäni® Sunrise™ (Paziņots 2014.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000500/2014
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Kyäni Europe AB
Manufacturer
Kyäni Inc.
Origin
Zviedrija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
30 ml no rīta
Published pack size
900 ml ( 30 ml x 30)
Published packaging
30 ml

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 60 ; mgVitamine CVitamin or mineral
B1 VITAMĪNSvitamins ; B1 VITAMĪNS ; 1.95 ; mgVitamine B1 (thiamine)Vitamin or mineral
B2 VITAMĪNSvitamins ; B2 VITAMĪNS ; 1.7 ; mgVitamine B2 (riboflavine)Vitamin or mineral
NIACĪNSvitamins ; NIACĪNS ; 25 ; mg NEVitamine B3 (niacine)Vitamin or mineral
B6 VITAMĪNSvitamins ; B6 VITAMĪNS ; 2.1 ; mgVitamine B6Vitamin or mineral
B12 VITAMĪNSvitamins ; B12 VITAMĪNS ; 3 ; μgVitamine B12Vitamin or mineral
PANTOTĒNSKĀBEvitamins ; PANTOTĒNSKĀBE ; 15 ; mgAcide pantothénique (vitamine B5)Vitamin or mineral
FOLSKĀBEvitamins ; FOLSKĀBE ; 200 ; μgFolates (vitamine B9)Vitamin or mineral
BIOTĪNSvitamins ; BIOTĪNS ; 150 ; μgBiotine (vitamine B8)Vitamin or mineral
Balto vīnogu sulas koncentrātsplants ; Balto vīnogu sulas koncentrāts ; Vitis vinifera L.vitis viniferaPlant
Bumbieru sulas koncentrātsplants ; Bumbieru sulas koncentrāts ; Pyrus communis L.pyrus communisPlant
Konkorda vīnogu sulas koncentrātsplants ; Konkorda vīnogu sulas koncentrāts ; Vitis labrusca L.vitis labruscaPlant
Ziemeļu melleņu sulas koncentrātsplants ; Ziemeļu melleņu sulas koncentrāts ; Vaccinium corymbosum L.vaccinium corymbosumPlant
Aroniju sulas koncentrātsplants ; Aroniju sulas koncentrāts ; Aronia melanocarpa (Michx.) Elliottaronia melanocarpaPlant
Granātābolu sulas koncentrātsplants ; Granātābolu sulas koncentrāts ; Punica granatumpunica granatumPlant
Aveņu sulas koncentrātsplants ; Aveņu sulas koncentrāts ; Rubus idaeus L.rubus idaeusPlant
Dzidrināta laima sulaplants ; Dzidrināta laima sula ; Citrus ×latifolia TanakaNot recognisedRole not identified
Vīnogu miziņu sausais ekstrakts 6:1plants ; Vīnogu miziņu sausais ekstrakts 6:1 ; Vitis vinifera L.vitis viniferaPlant
Mangostānas sulas koncentrātsplants ; Mangostānas sulas koncentrāts ; Garcinia mangostana L.garcinia mangostanaPlant
Aļaskas savvaļas mellenesplants ; Aļaskas savvaļas mellenes ; Vaccinium uliginosum L.vaccinium uliginosumPlant
Spinātu pulverisplants ; Spinātu pulveris ; Spinacia oleracea L.spinacia oleraceaPlant
Granātābolu ekstraktsplants ; Granātābolu ekstrakts ; Punica granatum L.punica granatumPlant
Alvejas jeb Aloe vera lapu gēla ekstraktsplants ; Alvejas jeb Aloe vera lapu gēla ekstrakts ; Aloe vera (L.) Burm.f. sin. Aloe barbadensis Mill.Not recognisedRole not identified
Brokoļu pulverisplants ; Brokoļu pulveris ; Brassica oleracea Italica Groupbrassica oleraceaPlant
Lapu kāpostu pulverisplants ; Lapu kāpostu pulveris ; Brassica oleracea Acephala Groupbrassica oleraceaPlant
Āzijas žeņšeņa ekstraktsplants ; Āzijas žeņšeņa ekstrakts ; Panax ginsengpanax ginsengPlant
Dzērveņu ekstraktsplants ; Dzērveņu ekstrakts ; Vaccinium macrocarponvaccinium macrocarponPlant
Akai ogu ekstraktsplants ; Akai ogu ekstrakts ; Euterpe oleracea Mart.euterpe oleraceaPlant
Amlas ogu pulverisplants ; Amlas ogu pulveris ; Emblica officinalis Gaertn. syn Phyllanthus emblica L.Not recognisedRole not identified
Vīnogu sēkliņu ekstraktsplants ; Vīnogu sēkliņu ekstrakts ; Vitis vinifera L.vitis viniferaPlant
ŪdensotherIngredients ; ŪdensNot recognisedRole not identified
FruktozeotherIngredients ; FruktozeNot recognisedRole not identified
Dabiskās krāsvielas, kas iegūtas no burkāniem un mellenēm (Exberry sarkanais tonis)otherIngredients ; Dabiskās krāsvielas, kas iegūtas no burkāniem un mellenēm (Exberry sarkanais tonis)Not recognisedRole not identified
Ābolskābe (E 296)otherIngredients ; Ābolskābe (E 296)Listed as food additive E 296 (EU Union list)Role not identified
Citronskābe (E 330)otherIngredients ; Citronskābe (E 330)Listed as food additive E 330 (EU Union list)Role not identified
Ksantāna sveķi (E 415)otherIngredients ; Ksantāna sveķi (E 415)Listed as food additive E 415 (EU Union list)Role not identified
Dabisks aveņu aromatizētājsotherIngredients ; Dabisks aveņu aromatizētājsNot recognisedRole not identified
Kālija sorbāts (E 202)otherIngredients ; Kālija sorbāts (E 202)Listed as food additive E 202 (EU Union list)Role not identified
Nātrija benzoāts (E 211)otherIngredients ; Nātrija benzoāts (E 211)Listed as food additive E 211 (EU Union list)Role not identified
Steviolglikozīdi (E 960)otherIngredients ; Steviolglikozīdi (E 960)Not recognisedRole not identified
InozītsotherIngredients ; Inozīts ; 25 ; mgNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Amerikas Savienotās Valstis

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ziemeļu melleņu sulas koncentrāts
    Read the warning, when it applies and the studies cited

    Blueberry

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Sources cited by Health Canada (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Randomised trial
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Health Canada monograph dated 29 August 2025

  • Granātābolu sulas koncentrāts
    Read the warning, when it applies and the studies cited
  • Āzijas žeņšeņa ekstrakts
    Read the warning, when it applies and the studies cited

    PANAX GINSENG

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).

    Sources cited by Health Canada (8)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Chin RKH. Ginseng and common pregnancy disorders. Asia-Oceania Journal of Obstetrics and Gynaecology 1991;17(4):379-380. PubMed
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of Panax ginseng during pregnancy and lactation. The Canadian Journal of Clinical Pharmacology 2008;15(1):e87-e94.
    • Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomised trial
    • Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995;18(10):1373-1375. PubMed Clinical trial
    • Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. Can red ginseng control blood glucose in diabetic patients. The Ginseng Review 2000;28:44-47.
    • Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).

    Sources cited by Health Canada (8)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dasgupta A, Reyes MA. Effect of Brazillian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab Fragment of antidigoxin antibody (Digiband). American Journal of Clinical Pathology 2005;124(2):229-236. PubMed
    • Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. Journal of Clinical Psychopharmacology 1995;15(6):447-448. PubMed Case report
    • Janetzki K, Morreale AP. Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997;54(6):692-693.
    • Jones BD, Runikis AM. Interaction of ginseng with phenelzine. Journal of Clinical Pharmacology 1987;7(3):201-202. PubMed Case report
    • Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. The Journal of Alternative and Complementary Medicine 2008a;14(6):715-721. PubMed Randomised trial
    • Shader RI, Greenblatt DJ. Bees, ginseng and MAOIs revisited. Journal of Clinical Psychopharmacology 1988;8(4):235. PubMed Case report
    • Shader RI, Greenblatt DJ. Phenelzine and the dream machine – ramblings and reflections. Journal of Clinical Psychopharmacology 1985;5(2):65. PubMed Case report

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).

    Sources cited by Health Canada (1)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).

    Sources cited by Health Canada (8)
    • Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety 2002;25(5):323-344. PubMed Systematic review
    • de Andrade E, de Masquita AA, de Almeida Claro J, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology 2007;9(2):241-244.
    • Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. The Annals of Pharmacotherapy 2002;36(3):375-379. PubMed Randomised trial
    • Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Disease and Associated Disorders 2008b;22(3):222-226. PubMed Randomised trial
    • Scaglione F, Weiser K, Alessandria M. Effects of the standardised ginseng extract G115 in patients with chronic bronchitis. Clinical Drug Investigation 2001;21(1):41-45.
    • Siegel RK. Ginseng abuse syndrome. Problems with the panacea. The Journal of the American Medical Association 1979;241(15):1614-1615. PubMed
    • Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomised trial
    • Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomised trial

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 June 2025

  • Dzērveņu ekstrakts
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • Akai ogu ekstrakts
    Read the warning, when it applies and the studies cited

    ACAI – EUTERPE OLERACEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Kyäni® Sunrise™ (Paziņots 2014.)”, https://compoatlas.com/en/supplements/latvia/4578-kyani-sunrisetm-pazinots-2014, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line